Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salah-Edin Al-Batran

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|November 6, 2020
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trialVolker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2025
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancerLena Weiss, Sebastian Stintzing, Arndt Stahler, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|November 6, 2020
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trialVolker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2025
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancerLena Weiss, Sebastian Stintzing, Arndt Stahler, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, et al.
Pageof 1